Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1516)
All Articles published online
|
Publishing Process of This Article
|
Sep 15, 2025 (publication date) through Apr 30, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Zhang CY, Liu S, Yang M. Macrophage and inflammation in diabetes and metabolic dysfunction-associated steatotic liver disease: From mechanisms to therapeutic strategies. World J Diabetes 2025; 16(9): 110515 [PMID: 40980303 DOI: 10.4239/wjd.v16.i9.110515] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Zhang CY, Liu S, Yang M. Macrophage and inflammation in diabetes and metabolic dysfunction-associated steatotic liver disease: From mechanisms to therapeutic strategies. World J Diabetes 2025; 16(9): 110515 [PMID: 40980303 DOI: 10.4239/wjd.v16.i9.110515] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i9/110515.htm |
| Number | Citing Articles |
| 1 |
Dariusz Szukiewicz. Special Issue “Fractalkine (CX3CL1) and Its Chemoattractant and Adhesion Molecule Properties in Health and Disease”. International Journal of Molecular Sciences 2025; 26(22): 10899 doi: 10.3390/ijms262210899
|
| 2 |
Yi Zhang, Haixin Ding, Xue Zhao, Yutong Li, Pengling Ge. The immunometabolic network in obesity-associated insulin resistance: a systemic multi-organ and multi-cellular perspective. International Immunopharmacology 2026; 177: 116528 doi: 10.1016/j.intimp.2026.116528
|
| 3 |
Bo Zhu. Synergistic therapeutic strategies for metabolic dysfunction-associated steatohepatitis and type 2 diabetes mellitus: molecular insights and clinical advances. Frontiers in Endocrinology 2026; 16 doi: 10.3389/fendo.2025.1753393
|
| 4 |
Kaipeng Hu, Siyuan Liu, Shuyan Sheng, Shaobo Zhang, Binghua Li, Beicheng Sun, Anliang Xia. Heterogeneity of hepatic macrophages in MASLD/MASH: Lipid-associated programs, molecular mechanisms, spatial niches, and therapeutic implications. iLIVER 2026; : 100234 doi: 10.1016/j.iliver.2026.100234
|
| 5 |
Lifen Xue, Xin Wang, Jingxin Mao. Research progress on the mechanistic pathways and biomarkers of therapeutic drugs for metabolic-associated steatotic liver disease. Frontiers in Cell and Developmental Biology 2026; 14 doi: 10.3389/fcell.2026.1808135
|